MedTrace Logo

Characterisation of the Human Carboxylesterase 1 (CES1) Mutations in Thailand

NCT01443806 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2018-06-27

No results posted yet for this study

Summary

The aim of this study is to evaluate the conversion of OP to OC in individual X and the family member of individual X. The investigators hypothesize that one or more of the single nucleoprotein polymorphisms (SNPs) of the CES1 gene represent a clinically important functional polymorphism.

Conditions

  • Metabolic Disease

Interventions

DRUG

Oseltamivir

75 mg, one time

Sponsors & Collaborators

  • South East Asia Infectious Disease Clinical Research Network

    collaborator NETWORK

  • University of Oxford

    lead OTHER

Principal Investigators

  • Sasithon Pukrittayakamee, MD. · Mahidol University

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01443806 on ClinicalTrials.gov